Multicenter experience of nonpegylated liposomal doxorubicin use in the management of metastatic breast cancer.
Saved in:
| Title: | Multicenter experience of nonpegylated liposomal doxorubicin use in the management of metastatic breast cancer. |
|---|---|
| Authors: | Palmieri C; Department of Medical Oncology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom; Liverpool and Merseyside Academic Unit, Cancer Services, Royal Liverpool University Hospital, Liverpool, United Kingdom; Academic Department of Medical Oncology, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom. Electronic address: c.palmieri@liverpool.ac.uk., Misra V; The Christie NHS Foundation Trust, Manchester, United Kingdom., Januszewski A; Department of Medical Oncology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Yosef H; The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Ashford R; Mount Vernon Cancer Centre, Northwood, Middlesex, United Kingdom., Keary I; Strategen Limited, Basingstoke, United Kingdom., Davidson N; Helen Rollason Cancer Charity, Chelmsford, Essex, United Kingdom. |
| Source: | Clinical breast cancer [Clin Breast Cancer] 2014 Apr; Vol. 14 (2), pp. 85-93. Date of Electronic Publication: 2013 Oct 27. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
